Patents by Inventor Harriet Wikman

Harriet Wikman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130130966
    Abstract: The present invention relates to the field of tumor biology. It provides a method for determining the risk of metastasis of a tumor, in particular, the risk of hematogenous dissemination and/or homing/survival in bone marrow, wherein the expression of RAI2, and optionally of other genes, in a tumor sample obtained from the patient is determined. The invention further provides a kit for determining the expression of RAI2 and/or other genes. A pharmaceutical composition comprising RAI2 in gene or protein form is disclosed, in particular for preventing and/or treating metastasis of a tumor.
    Type: Application
    Filed: April 20, 2011
    Publication date: May 23, 2013
    Applicant: Universitätsklinikum Hamburg-Eppendorf
    Inventors: Harriet Wikman, Klaus Pantel, Stefan Werner
  • Publication number: 20100279281
    Abstract: The present invention is related to a method for assessing the presence of, or disposition to, an asbestos-related disorder in a subject. Particularly, the invention provides a method of identifying lung cancers associated with asbestos-exposure. The association is confirmed by the detection of allelic imbalance (AI) in at least one of the following chromosomal regions of lung cancer cells: 19p13.3-p13.1; 9q32-34.3; 2p21-p16.3; 16p13.3; 22q12.3-q13.1; and 5q35.3.
    Type: Application
    Filed: January 18, 2007
    Publication date: November 4, 2010
    Applicant: LICENTIA LTD.
    Inventors: Sisko Anttila, Sakari Knuutila, Jaakko Hollmen, Salla Ruosaari, Harriet Wikman-Kocher, Penny Nymark